Also, its presence is required for malignant transformation of NSCs and astrocytes; high levels of Bmi-1 expression facilitate high-grade gliomas in vivo, while low expressing Bmi-1 cells initiate or are associated with less malignant glioma [182]. This evidence concerns the gene BMI1 and central nervous system cancer.